Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP925946.RA1d8hoBWKUUwOiG5r1QsbXJUGqdL5ljfcWGG8U0B1bao130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP925946.RA1d8hoBWKUUwOiG5r1QsbXJUGqdL5ljfcWGG8U0B1bao130_assertion type Assertion NP925946.RA1d8hoBWKUUwOiG5r1QsbXJUGqdL5ljfcWGG8U0B1bao130_head.
- NP925946.RA1d8hoBWKUUwOiG5r1QsbXJUGqdL5ljfcWGG8U0B1bao130_assertion description "[They are attractive candidates for liver cancer therapy given that GPC3 and mesothelin show high expression in HCC and CCA, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP925946.RA1d8hoBWKUUwOiG5r1QsbXJUGqdL5ljfcWGG8U0B1bao130_provenance.
- NP925946.RA1d8hoBWKUUwOiG5r1QsbXJUGqdL5ljfcWGG8U0B1bao130_assertion evidence source_evidence_literature NP925946.RA1d8hoBWKUUwOiG5r1QsbXJUGqdL5ljfcWGG8U0B1bao130_provenance.
- NP925946.RA1d8hoBWKUUwOiG5r1QsbXJUGqdL5ljfcWGG8U0B1bao130_assertion SIO_000772 21942912 NP925946.RA1d8hoBWKUUwOiG5r1QsbXJUGqdL5ljfcWGG8U0B1bao130_provenance.
- NP925946.RA1d8hoBWKUUwOiG5r1QsbXJUGqdL5ljfcWGG8U0B1bao130_assertion wasDerivedFrom befree-2016 NP925946.RA1d8hoBWKUUwOiG5r1QsbXJUGqdL5ljfcWGG8U0B1bao130_provenance.
- NP925946.RA1d8hoBWKUUwOiG5r1QsbXJUGqdL5ljfcWGG8U0B1bao130_assertion wasGeneratedBy ECO_0000203 NP925946.RA1d8hoBWKUUwOiG5r1QsbXJUGqdL5ljfcWGG8U0B1bao130_provenance.